The DOI matches its Crossref record; 343 of the 343 references it cites were found in a registry or an index.
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Abstract
At present, diabetic kidney disease affects about 15-25% of type 1 and 30-40% of type 2 diabetic patients. Several decades of extensive research has elucidated various pathways to be implicated in the development of diabetic kidney disease. This review focuses on the metabolic factors beyond blood glucose that are involved in the pathogenesis of diabetic kidney disease, i.e., advanced glycation end-products and the aldose reductase system. Furthermore, the contribution of hemodynamic factors, the renin-angiotensin system, the endothelin system, and the nitric oxide system, as well as the prominent role of the intracellular signaling molecule protein kinase C are discussed. Finally, the respective roles of TGF-beta, GH and IGFs, vascular endothelial growth factor, and platelet-derived growth factor are covered. The complex interplay between these different pathways will be highlighted. A brief introduction to each system and description of its expression in the normal kidney is followed by in vitro, experimental, and clinical evidence addressing the role of the system in diabetic kidney disease. Finally, well-known and potential therapeutic strategies targeting each system are discussed, ending with an overall conclusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–343 of 343
Flyvbjerg, A., Kessler, U., Dorka, B., Funk, B., �rskov, H., & Kiess, W. (1992) · Diabetologia · doi:10.1007/bf00400489 · Cited by 102
Self-citationVascular Endothelial Growth Factor Receptors in Human Mesangium in Vitro and in Glomerular Disease
Thomas, S., VANUYSTEL, J., Gruden, G., RODRÍGUEZ, V., Burt, D. J., Gnudi, L., HARTLEY, B., & Viberti, G. C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171236 · Cited by 102
Soulis, T., Cooper, M. E., Sastra, S. A., Thallas, V., Panagiotopoulos, S., Bjerrum, O. J., & Jerums, G. (1997) · Diabetologia · doi:10.1007/s001250050799 · Cited by 101
Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice
Chen, N. Y., Chen, W. Y., Bellush, L. L., Yang, C., Striker, L. J., Striker, G. E., & Kopchick, J. J. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835300 · Cited by 100
Ballesteros, M., Leung, K., Ross, R. J. M., Iismaa, T. P., & Ho, K. K. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6711 · Cited by 98
Gene expression for endothelins and their receptors in glomeruli of diabetic rats.
Fukui, M., Nakamura, T., Ebihara, I., Osada, S., Tomino, Y., Masaki, Τ., Goto, K., Furuichi, Y., & Koide, H. (1993) · PubMed · Cited by 98
Kim, S. I., Han, D. C., & Lee, H. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11180 · Cited by 97
Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion
McCarthy, K. J., Routh, R. E., Shaw, W., Walsh, K., Welbourne, T., & Johnson, J. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00418.x · Cited by 96
Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells.
Bakris, G., & Ré, R. (1993) · American Journal of Physiology · doi:10.1152/ajprenal.1993.264.6.f937 · Cited by 96
Localization of endothelin peptides in human kidney
Karet, F. E., & Davenport, A. P. (1996) · Kidney International · doi:10.1038/ki.1996.56 · Cited by 94
Reyes, A. A., Karl, I. E., Kissane, J. M., & Klahr, S. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v441039 · Cited by 94
He, C., Koschinsky, T., Bünting, C. E., & Vlassara, H. (2001) · Molecular Medicine · doi:10.1007/bf03401949 · Cited by 93
Serri, O., Beauregard, H., Brazeau, P., Abribat, T., Lambert, J., Harris, A. A., & Vachon, L. (1991) · JAMA · doi:10.1001/jama.1991.03460070070045 · Cited by 93
Characterization of the Renal Phenotype of Transgenic Rats Expressing the Human Endothelin-2 Gene
Hocher, B., Liefeldt, L., Thöne‐Reineke, C., Orzechowski, H., Distler, A., Bauer, C., & Paul, M. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.196 · Cited by 92
Berg, T. J., Clausen, J. T., Torjesen, P. A., Dahl‐Jørgensen, K., Bangstad, H. ‐., & Hanssen, K. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1997 · Cited by 90
Ceolotto, G., Gallo, A., Miola, M., Sartori, M., Trevisan, R., Prato, S. D., Semplicini, A., & Avogaro, A. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1316 · Cited by 90
Hill, C., Flyvbjerg, A., Rasch, R., Bak, M., & Logan, A. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700647 · Cited by 90
Self-citationRj, K., Gardiner, S. M., Compton, A. M., & Bennett, T. M. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09787.x · Cited by 88
Whittle, C., Gillespie, K. M., Harrison, R., Mathieson, P. W., & Harper, S. J. (1999) · Clinical Science · doi:10.1042/cs0970303 · Cited by 88
Ohishi, K., & Carmines, P. K. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v581559 · Cited by 88
Vriese, A. S. D., de Voorde, J. V., Blom, H. J., Vanhoutte, P. M., Verbeke, M., & Lameire, N. H. (2000) · Diabetologia · doi:10.1007/s001250051502 · Cited by 86
Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA
Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J., & Kokai, Y. (1995) · Diabetologia · doi:10.1007/bf00400627 · Cited by 85
Tuttle, K. R., & Anderson, P. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00741-8 · Cited by 85
Jerums, G., Allen, T. J., Campbell, D. J., Cooper, M. E., Gilbert, R. E., Hammond, J. J., Jf, R., & Tsalamandris, C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(05)80003-4 · Cited by 85
Bellush, L. L., Doublier, S., Holland, A. N., et al. (2000) · Endocrinology · doi:10.1210/endo.141.1.7284 · Cited by 84
A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM
Fogarty, D. G., Harron, J. C., Hughes, A. E., Nevin, N. C., Doherty, C., & Maxwell, A. P. (1996) · Diabetes · doi:10.2337/diab.45.9.1204 · Cited by 84
He, C., Zheng, F., Stitt, A. W., Striker, L. J., Hattori, M., & Vlassara, H. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00365.x · Cited by 83
Aldose reductase inhibitors and diabetic complications
Raskin, P., & Rosenstock, J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90702-9 · Cited by 83
Yang, C., Hattori, M., Vlassara, H., He, C., Carome, M. A., Yamato, E., Elliot, S. J., Striker, G. E., & Striker, L. J. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v581610 · Cited by 82
Early streptozotocin-diabetes mellitus downregulates rat kidney AT2receptors
Wehbi, G. J., Zimpelmann, J., Carey, R. M., Levine, D. Z., & Burns, K. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f254 · Cited by 82
Keogh, R. J., Dunlop, M., & Larkins, R. G. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90165-7 · Cited by 80
Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells
Kim, N. H., Jung, H., Cha, D., & Choi, D.-S. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650617 · Cited by 80
Phillips, A. O., Steadman, R., Morrisey, K., Martin, J. T., Eynstone, L. V., & Williams, J. D. (1997) · Kidney International · doi:10.1038/ki.1997.419 · Cited by 79
Shah, V. O., Scavini, M., Nikolic, J., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5028 · Cited by 79
Ito, A., Egashira, K., Narishige, T., Muramatsu, K., & Takeshita, A. (2002) · Circulation Journal · doi:10.1253/circj.66.811 · Cited by 77
Inaba, T., Ishibashi, S., Gotoda, T., et al. (1996) · Diabetes · doi:10.2337/diab.45.4.507 · Cited by 76
Mizuno, M., Sada, T., Kato, M., & Koike, H. (2002) · Hypertension Research · doi:10.1291/hypres.25.271 · Cited by 76
[Growth hormone-binding protein].
Takeda, S., & Inoue, K. (1995) · PubMed · Cited by 76
Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: Role of nitric oxide
Vriese, A. S. D., Stoenoiu, M. S., Elger, M., Devuyst, O., Vanholder, R. C., Kriz, W., & Lameire, N. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00787.x · Cited by 74
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding
Youssef, S., Nguyen, D. T., Soulis, T., Panagiotopoulos, S., Jerums, G., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003907.x · Cited by 74
Tarnow, L. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.5.1125 · Cited by 74
Renal nitric oxide production during the early phase of experimental diabetes mellitus
Keynan, S., Hirshberg, B., Levin-Iaina, N., Wexler, I. D., Dahan, R., Reinhartz, E., Ovadia, H., Wollman, Y., Chernihovskey, T., Iaina, A., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00220.x · Cited by 73
Passariello, N., Sepe, J. J., Marrazzo, G., Cicco, A. D., Peluso, A., Plsano, M., Sgambato, S., Tesauro, P., & D'Onofrio, F. (1993) · Diabetes Care · doi:10.2337/diacare.16.5.789 · Cited by 73
Ishii, H., Tada, H., & Isogai, S. (1998) · Diabetologia · doi:10.1007/s001250050916 · Cited by 72
Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H., & Bucala, R. (2001) · Molecular Medicine · doi:10.1007/bf03401963 · Cited by 70
Duraisamy, S., Choudhury, G. G., McLaurin, C., & Kasinath, B. S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00135.x · Cited by 70
Expression of a Novel PDGF Isoform, PDGF-C, in Normal and Diseased Rat Kidney
Eitner, F., Ostendorf, T., van Roeyen, C. R. C., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134910 · Cited by 70
Pichler, R. H., Bassuk, J. A., Hugo, C., Reed, M. J., Eng, E., GORDON, K. L., Pippin, J., Alpers, C. E., Couser, W. G., Sage, E. H., et al. (1996) · Europe PMC (PubMed Central) · Cited by 69
Angiotensin II Receptor Type 1 Gene Expression in Human Glomerulonephritis and Diabetes Mellitus
Wagner, J., Gehlen, F., Ciechanowicz, A., & Ritz, E. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103545 · Cited by 69
Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice
Segev, Y., Landau, D., Rasch, R., Flyvbjerg, A., & Phillip, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112374 · Cited by 68
Self-citationIso, K., Tada, H., Kuboki, K., & Inokuchi, T. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00160-x · Cited by 65
Insulinlike growth factor-1 is a progression factor for human mesangial cells.
Doi, T., Striker, L. J., Elliot, S. J., Conti, F., & Striker, G. E. (1989) · Europe PMC (PubMed Central) · Cited by 64
Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats
Wang, Y. X., Brooks, D. P., & Edwards, R. M. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.5.r952 · Cited by 63
Fraser, D. J., Wakefield, L. M., & Phillips, A. O. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64265-4 · Cited by 63
Endothelins: vasoactive modulators of renal function in health and disease
Naicker, S., & Bhoola, K. D. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00131-0 · Cited by 63
Combination ACEI and ARB therapy: additional benefit in renoprotection?
Taal, M. W., & Brenner, B. M. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200207000-00001 · Cited by 62
Sato, H., Iwano, M., Akai, Y., Kurioka, H., Kubo, A., Yamaguchi, T., Hirata, E., Kanauchi, M., & Dohi, K. (1998) · American Journal of Nephrology · doi:10.1159/000013415 · Cited by 62
Role of polyol pathway in nonenzymatic glycation
Hamada, Y., Araki, N., Horiuchi, S., & Hotta, N. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.95 · Cited by 62
Administration of AGEs in vivo induces extracellular matrix gene expression
Striker, L. J., & Striker, G. E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.62 · Cited by 61
Goppelt‐Struebe, M., Hahn, A., Iwanciw, D., Rehm, M., & Banas, B. (2001) · Molecular Pathology · doi:10.1136/mp.54.3.176 · Cited by 61
Effect of Puberty on Initial Kidney Growth and Rise in Kidney IGF-I in Diabetic Rats
Bach, L. A., & Jerums, G. (1990) · Diabetes · doi:10.2337/diab.39.5.557 · Cited by 61
Inhibitory Effects of Tenilsetam on the Maillard Reaction
Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 61
Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.
Ravid, M., Savin, H., Jutrin, I., Bental, T., Lang, R., & Lishner, M. (1994) · PubMed · Cited by 61
Lee, I. K., Koya, D., Ishi, H., Kanoh, H., & King, G. L. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00048-0 · Cited by 60
Tran, K. T., Proulx, P. R., & Chan, A. C. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90253-4 · Cited by 59
Kasajima, H., Yamagishi, S., Sugai, S., Yagihashi, N., & Yagihashi, S. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100444 · Cited by 59
O'Byrne, S., Forte, P., Roberts, L. J., Morrow, J. D., Johnston, A. E., Änggård, E., Leslie, R. D. G., & Benjamin, N. (2000) · Diabetes · doi:10.2337/diabetes.49.5.857 · Cited by 59
Rudberg, S. L., Rasmussen, L. M., Bangstad, H. ‐., & Østerby, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.544 · Cited by 58
Aldose Reductase Gene Expression Is Increased in Diabetic Nephropathy1
Shah, V. O., Dorin, R. I., Sun, Y., BRAUN, M. A., & Zager, P. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4082 · Cited by 58
Renal ACE immunohistochemical localization in NIDDM patients with nephropathy
Mizuiri, S., Yoshikawa, H., Tanegashima, M., Miyagi, M., Kobayashi, M., Sakai, K., Hayashi, I., Aikawa, A., Ohara, T., & Hasegawa, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9469501 · Cited by 57
High Glucose Increases Inducible NO Production in Cultured Rat Mesangial Cells
Noh, H., Ha, H., Yu, M. R., Kang, S., Choi, K. H., Han, D. S., & Lee, H. Y. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046318 · Cited by 57
Over-expression of platelet-derived growth factor in human diabetic nephropathy
Langham, R. G., Kelly, D. J., Maguire, J. A., et al. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg177 · Cited by 57
Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells
Cohen, M. P., Ziyadeh, F. N., Lautenslager, G. T., et al. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f684 · Cited by 57
Nankervis, A. J., Nicholls, K., Kilmartin, G., Allen, P., Ratnaike, S., & Martin, F. I. R. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90364-x · Cited by 56
Morrisey, K., Steadman, R., Williams, J. D., & Phillips, A. O. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00248.x · Cited by 56
High glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1
Glogowski, E., Tsiani, E., Zhou, X., Fantus, I. G., & Whiteside, C. I. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00284.x · Cited by 56
Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro
Routh, R. E., Johnson, J. H., & McCarthy, K. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00277.x · Cited by 55
Seifert, R. A., Alpers, C. E., & Bowen‐Pope, D. F. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00046.x · Cited by 55
Hiragushi, K., Sugimoto, H., Shikata, K., Yamashita, T., Miyatake, N., Shikata, Y., Wada, J., Kumagai, I., Fukushima, M., & Makino, H. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00260-1 · Cited by 55
High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent
Schrijvers, B. F., Rasch, R., Tilton, R. G., & Flyvbjerg, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00310.x · Cited by 55
Self-citationWong, T. Y. H., Chan, J. C. N., Poon, E., & Li, P. K. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70143-5 · Cited by 55
Prevention of decline in renal function in the diabetic db/db mouse
Cohen, M. P., Clements, R. S., Cohen, J. A., & Shearman, C. W. (1996) · Diabetologia · doi:10.1007/bf00418341 · Cited by 54
Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule
Bleyer, A. J., Fumo, P., Snipes, E. R., Goldfarb, S., Simmons, D. A., & Ziyadeh, F. N. (1994) · Kidney International · doi:10.1038/ki.1994.88 · Cited by 53
Ruggenenti, P. L., Mosconi, L., Sangalli, F., Casiraghi, F., Gambara, V., Remuzzi, G., & Remuzzi, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003984.x · Cited by 53
Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo
Harper, S. J., Xing, C. Y., Whittle, C., PARRY, R., Gillatt, D. A., Peat, D., & Mathieson, P. W. (2001) · Clinical Science · doi:10.1042/cs1010439 · Cited by 51
Honkanen, E. O., Teppo, A., & Grönhagen‐Riska, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00094.x · Cited by 50
Cao, Z., Bonnet, F., DAVIS, B., Allen, T. J., & Cooper, M. E. (2001) · Clinical Science · doi:10.1042/cs1000591 · Cited by 50
McLaren, M., Elhadd, T. A., Greene, S. A., & Belch, J. J. F. (1999) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969900500105 · Cited by 50
Localization of PDGF α-receptor in the developing and mature human kidney
Floege, J., Hudkins, K. L., Seifert, R. A., Francki, A., Bowen‐Pope, D. F., & Alpers, C. E. (1997) · Kidney International · doi:10.1038/ki.1997.157 · Cited by 49
Regulation of endothelin-1 production in cultured rat mesangial cells
Sakamoto, H., Sasaki, S., Nakamura, Y., Fushimi, K., & Marumo, F. (1992) · Kidney International · doi:10.1038/ki.1992.48 · Cited by 49
Tack, I., Elliot, S. J., Potier, M., Rivera, A., Striker, G. E., & Striker, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.1.182 · Cited by 49
Activation of transforming growth factor-β1 in diabetic kidney disease
Hellmich, B., Schellner, M., Schatz, H., & Pfeiffer, A. F. H. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90264-6 · Cited by 48
Shin, S. J., Lai, F., Wen, J., Hsiao, P., Hsieh, M., Tzeng, T. F., Chen, H. C., Guh, J. Y., & Tsai, J. H. (2000) · Diabetologia · doi:10.1007/s001250051354 · Cited by 48
Raccah, D., Coste, T. C., Cameron, N. E., Dufayet, D., Vague, P., & Hohman, T. C. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00093-7 · Cited by 48
Soulis, T., Sastra, S. A., Thallas, V., Mortensen, S. B., Wilken, M., Clausen, J. T., Bjerrum, O. J., Petersen, H., Lau, J. F., Jerums, G., et al. (1999) · Diabetologia · doi:10.1007/s001250051181 · Cited by 46
Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan, S. (1993) · PubMed · Cited by 45
Gugliucci, A., & Bendayan, M. (1995) · Journal of Histochemistry & Cytochemistry · doi:10.1177/43.6.7769229 · Cited by 45
Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients
Pedersen, M. M., Christensen, S. E., Christiansen, J. S., Pedersen, E. B., Mogensen, C. E., & Ørskov, H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01394.x · Cited by 45
Aldose Reductase Gene Expression Is Increased in Diabetic Nephropathy
Shah, V. O. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2294 · Cited by 42
Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats
Osicka, T. M., Kiriazis, Z., Pratt, L. M., Jerums, G., & Comper, W. D. (2001) · Diabetologia · doi:10.1007/s001250051604 · Cited by 41
Additive Effects of Enalapril and Losartan in (mREN-2)27 Transgenic Rats
Richer, C., Bruneval, P., Ménard, J., et al. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.692 · Cited by 41
Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats
Pflueger, A. C., Larson, T. S., Hagl, S., et al. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r725 · Cited by 40
Yoshii, H., Uchino, H., Ohmura, C., Watanabe, K., Tanaka, Y., & Kawamori, R. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00221-7 · Cited by 39
Braun, L., Kardon, T., Reisz-Porszasz, Z., Bánhegyi, G., & Mandl, J. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01327-3 · Cited by 39
Inhibiting Albumin Glycation Ameliorates Diabetic Nephropathy in the db/db Mouse
Cohen, M. P., Masson, N., Hud, E., Ziyadeh, F. N., Han, D. C., & Clements, R. S. (2000) · Nephron Experimental Nephrology · doi:10.1159/000020661 · Cited by 39
Shah, V. O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2886 · Cited by 38
A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse
Landau, D., Segev, Y., Afargan, M., Silbergeld, A., Kachko, L., Podshyvalov, A., & Phillip, M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002505.x · Cited by 36
Mallee, J. J., Atta, M. G., Lorica, V., Rim, J. S., Kwon, H. M., Lucente, A. D., Wang, Y., & Berry, G. T. (1997) · Genomics · doi:10.1006/geno.1997.5055 · Cited by 35
The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats
Itagaki, I., Shimizu, K., Kamanaka, Y., Ebata, K., Kikkawa, R., Haneda, M., & Shigeta, Y. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90002-7 · Cited by 35
Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats
Oturai, P., Christensen, M., Rolin, B., et al. (2000) · Metabolism · doi:10.1053/meta.2000.7731 · Cited by 34
Grønbæk, H., Vogel, I., Østerby, R., Lancranjan, I., Flyvbjerg, A., & Ørskov, H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00720.x · Cited by 33
Self-citationAcute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat
KELLY, F. J., Anderson, S. F., Thompson, M. M., Oyama, T., Kennefick, T. M., Corless, C. L., Roman, R. J., Kurtzberg, L. S., Pratt, B. M., & Ledbetter, S. R. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061264 · Cited by 33
Höpfner, R., Misurski, D. A., Wilson, T. W., McNeill, J. R., & Gopalakrishnan, V. (1998) · Diabetologia · doi:10.1007/s001250051057 · Cited by 32
Azar, S. T., Salti, I., Zantout, M. S., & Major, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4680 · Cited by 32
Araki, S., Ng, D., Krolewski, B., Wyrwicz, L. S., Rogus, J. J., Canani, L. H. S., Makita, Y., Haneda, M., Warram, J. H., & Królewski, A. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077347.27669.5c · Cited by 32
The TGF-β–Smad network: introducing bioinformatic tools
Kloos, D. U., Choi, C., & Wingender, E. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02556-8 · Cited by 32
Weir, M. R., & Henrich, W. L. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200007000-00012 · Cited by 32
Ballesteros, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2865 · Cited by 32
Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1
Cohen, M. P., Ziyadeh, F. N., Hong, S. W., Shearman, C. W., Hud, E., Lautenslager, G. T., de la Cruz, M. D. C. I., & Chen, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00352.x · Cited by 31
New therapies for advanced glycation end product nephrotoxicity: Current challenges
Williams, M. E. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50083 · Cited by 30
Available, N. A. N. (2000) · Diabetologia · doi:10.1007/s001250051493 · Cited by 30
Protein kinase C β I and β II are differentially expressed in the developing glomerulus
Saxena, R., Saksa, B. A., Hawkins, K. S., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.9.8005392 · Cited by 29
Tarnow, L., Kjeld, T., Knudsen, E., Major‐Pedersen, A., & Parving, H. ‐. (2000) · Diabetologia · doi:10.1007/s001250051377 · Cited by 29
Park, I.-S., Kiyomoto, H., Alvarez, F., Xu-Dubois, Y.-C., Abboud, H. E., & Abboud, S. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70075-7 · Cited by 28
Riley, S., Steadman, R., Williams, J. D., Floege, J., & Phillips, A. O. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90211-1 · Cited by 28
Localization and regulation of renal Na+/myo-inositol cotransporter in diabetic rats
Wiese, T. J., Matsushita, K., Lowe, W. L., Stokes, J. B., & Yorek, M. A. (1996) · Kidney International · doi:10.1038/ki.1996.429 · Cited by 25
An enzymatic cycling method for the measurement of myo-inositol in biological samples
Kouzuma, T., Takahashi, M., Endoh, T., Kaneko, R., Ura, N., Shimamoto, K., & Watanabe, N. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00614-3 · Cited by 24
Noda, M., Matsuo, T., Nagano-Tsuge, H., Ohta, M., Sekiguchi, M., Shibouta, Y., Naka, T., & Imura, Y. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.85.416 · Cited by 24
Mogyorósi, A., Kapoor, A., Isono, M., Kapoor, S. C., Sharma, K., & Ziyadeh, F. N. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045766 · Cited by 24
Grønbæk, H., Nielsen, B., Frystyk, J., Ørskov, H., & Flyvbjerg, A. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470095 · Cited by 23
Self-citationRanganathan, S., Krempf, M., Féraille, E., & Charbonnel, B. H. (1993) · PubMed · Cited by 23
Amiri, F., & Garcia, R. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f603 · Cited by 21
Pedersen, M. M., Ck, C., Hansen, K. W., Christiansen, J., & Ce, M. (1991) · PubMed · Cited by 21
Aldose and aldehyde reductases from human kidney cortex and medulla
Robinson, B., Hunsaker, L. A., Stangebye, L. A., & Jagt, D. L. V. (1993) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(93)90092-6 · Cited by 15
Crossline levels in serum and erythrocyte membrane proteins from patients with diabetic nephropathy
Aoki, S.-I., Hasegawa, G., Shigeta, H., Obayashi, H., Fujii, M., Kimura, F., Moriwaki, A., Nakamura, N., Ienaga, K., Nakamura, K., et al. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00148-5 · Cited by 15
Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats
Ishii, N., Ikenaga, H., Ogawa, Z., Aoki, Y., Saruta, T., & Suga, T. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563011900713 · Cited by 12
Holdaas, H., Hartmann, A., Berg, K., Langberg, H., Blystad, L., & Fauchald, P. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01141.x · Cited by 10
de Azevedo, M., Ramos, O. A., & Gross, J. L. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979092 · Cited by 10
Fujigaki, Y., Watanabe, T., Ikegaya, N., Yonemura, K., Sun, D. F., Hishida, A., Yamamoto, T., Kojima, K., & Nagase, M. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.2.191 · Cited by 8
Borrebæk, J., Prydz, K., FJELDSTAD, K., Vuong, T. T., Berg, T. J., Holkov, C., & Kolset, S. O. (2001) · Diabetologia · doi:10.1007/s001250051647 · Cited by 8
Effect Of Metabolic Control On Nitrite And Nitrate Metabolism In Type 2 Diabetic Patients
Francesconi, F., Mingardi, R., DeKreutzenberg, S., & Avogaro, A. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03479.x · Cited by 7
黄宇峰, 林善锬, & 周江华 (1998) · 中华医学杂志:英文版 · Cited by 4
Protein Kinase C in Diabetic Renal Involvement, the Perspective of its Inhibition
Gabriele, A., Koya, D., & King, G. L. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4499-9_22 · Cited by 3
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Chronic Kidney Disease and Exposure to Nephrotoxic Metals
Orr, S., & Bridges, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051039 · Cited by 434
The role of the complement system in diabetic nephropathy
Flyvbjerg, A. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.31 · Cited by 397
Self-citationAdvanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
Metadata
- Authors
- Schrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-12-01
- Volume
- 25
- Issue
- 6
- Pages
- 971-1010
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2105487207
- Cited by
- 353
- References
- 343
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.